Wed, Apr 23, 2014, 5:22 PM EDT - U.S. Markets closed

Recent

% | $
Quotes you view appear here for quick access.

Prana Biotechnology Limited Message Board

  • esoteric687 esoteric687 Jan 30, 2014 6:48 PM Flag

    Let's get real folks---You have a choice of judgements

    On one side, you have Adam Fuerstein, Martin Shkreli, some clown from the Motley Fool, and the Captain.
    On the other side you have, Credit Suisse, Summer Street Research, Louis navallier, and Rudy Tanzi.
    Make your choice!

    Sentiment: Strong Buy

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • Well, Adam Fuerstein (a political science major?!) was DEAD WRONG about VNDA, KERX, SRPT, ACAD, DNDN and so many others it is ridiculous.

      now... from wikipedia:

      Dr. Rudolph Tanzi is the Joseph P. and Rose F. Kennedy Professor of Neurology at Harvard University, and Director of the Genetics and Aging Research Unit at Massachusetts General Hospital (MGH).. Tanzi has been investigating the genetics of neurological disease since the 1980s when he participated in the first study that to use genetic markers to find a disease gene (Huntington's disease). Dr. Tanzi co-discovered the three familial early-onset Alzheimer's disease (FAD) genes and several other neurological disease genes including that responsible for Wilson’s disease. As the leader of the Cure Alzheimer’s Fund Alzheimer’s Genome Project, Dr. Tanzi has carried out multiple genome wide association studies of thousands of Alzheimer’s families leading to the identification of novel AD candidate genes, including CD33 and the first two rare mutations causing late-onset AD in the ADAM10 gene. His research on the role of zinc and copper in AD has led recently to successful clinical trials at Prana Biotechnology. He is also working gamma secretase modulators (together with Dr. Steve Wagner, UCSD) for the prevention and treatment of Alzheimer's.

      Tanzi serves on dozens of editorial and scientific advisory boards, and as Chair of the Cure Alzheimer’s Fund Research Consortium. He has received numerous awards, including the two highest awards for Alzheimer's disease research: The Metropolitan Life Award and The Potamkin Prize. He was included on the list of the "Harvard 100 Most Influential Alumni", and was chosen by the Geoffrey Beene Foundation as a “Rock Star of Science”. Dr. Tanzi has co-authored over 450 research articles, including three of the top ten most cited AD papers.

      Sentiment: Strong Buy

    • In the long run I trust the former

    • To decide, all I need to do is use my SUPER BRAIN. Thanks Rudy!

      Sentiment: Strong Buy

    • Dr. Tanzi and Credit Suisse.

 
PRAN
2.04-0.08(-3.77%)Apr 23 4:00 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.